3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Inflammation
1
Disease Progression
1
Arthritis, Rheumatoid
1
Interventions
Methotrexate
4
veltuzumab
1
tocilizumab
1
andecaliximab
1
Tumor Necrosis Factor Inhibitors
1
RC-18
1
Nivolumab
1
Interleukin 1 Receptor Antagonist Protein
1
Folic Acid
1
Etanercept
1
Bortezomib
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Arthritis, Rheumatoid
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT00537667
2009-11-26
The SPECTRA Study
Swedish Orphan Biovitrum
Phase 2
Terminated
22 enrolled